HOME >> BIOLOGY >> NEWS
Cornell scientists link E. coli bacteria to Crohn's disease

ITHACA, N.Y. A team of Cornell University scientists from the College of Veterinary Medicine, Weill Cornell Medical College and the College of Agriculture and Life Sciences have discovered that a novel group of E. coli bacteria containing genes similar to those described in uropathogenic and avian pathogenic E. coli and enteropathogenic bacteria such as salmonella, cholera, bubonic plague is associated with intestinal inflammation in patients with Crohns disease in their research paper published July 12 by The ISME Journal: Multidisciplinary Journal of Microbial Ecology.

Crohns disease, an incurable inflammatory disorder of the intestine most commonly found in the lower part of the small intestine called the ileum affects 1-in-1,000 people in Europe and North America. Thus far, gut bacteria have long been suspected in playing a pivotal role in the development of Crohns disease, but the specific bacterial characteristics that drive the inflammatory response have remained elusive.

Researchers at Cornell examined possible causes for the disease in patients with Crohns restricted to the ileum and the colon versus healthy individuals.

Given that only about 20 percent of fecal bacteria can be cultured, our group adopted a broad culture-independent approach to target specific subgroups of bacteria for quantitative in situ analysis and culture based characterization, said Kenneth Simpson, professor of small animal medicine at the College of Veterinary Medicine. Our findings raise the possibility that a novel group of E. coli contains opportunistic pathogens that may be causally related to chronic intestinal inflammation in susceptible individuals. They suggest that an integrated approach that considers an individuals mucosa-associated flora in addition to disease phenotype and genotype may improve outcome.

The study found an increased level of E. coli bacteria in more inflamed areas of the small intestines instead of MAP, a bacterium related
'"/>

Contact: Sabina Lee
ssl37@cornell.edu
607-255-3024
Cornell University News Service
7-Aug-2007


Page: 1 2

Related biology news :

1. Weill Cornell team identifies potential new cancer drug target
2. Methodist, University of Houston, Cornell combine biomedical imaging expertise
3. Weill Cornell pharmacologist receives prestigious NIH MERIT Award
4. Cornell lab confirms deadly fish virus spreading to new species
5. NSF awards $3.3 million grant to Cornell to bolster the percentage of women faculty members
6. Cornell researchers find serious fish virus in Northeast for first time
7. Cornell finds natural selection in humans
8. Northeast Sun Grant Institute at Cornell spurs green revolution
9. Stem cell research at Weill Cornell, The Rockefeller University, and Sloan-Kettering
10. Cornell graduate student named 2005 AIBS Emerging Public Policy Leader
11. Weill Cornell team develops fast-acting anthrax vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received ... innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts to be assigned ... syringe. The company’s solutions are the first Wharton’s jelly allograft product to be recognized ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... therapeutics product portfolio with a near term focus on Type 2 diabetes and ... commercialization experience across multiple therapeutic areas and classes. As Chief Commercial Officer, Justin ...
(Date:7/18/2020)... ... , ... Commercial launch readiness is a critical stage in a product life ... vaccine, the global economic downturn will only increase price pressures overall for the industry. ... full value from every product launch is critical. However, history shows that only a ...
Breaking Biology News(10 mins):
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now offering stem ... 200 million stem cells. Depending on the patient's condition, treatment may be offered IV, ... die having some form of Alzheimers dementia, and the incidence continues to increase as ...
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a leading provider of ... businesses of all types to ensure cleanliness, distancing and occupancy with its patent pending ... Space™ enabled business will provide a health performance index system that scores all aspects ...
(Date:6/23/2020)... ... 23, 2020 , ... DeCurtis Corporation, the premier provider of ... Fournier has been appointed CEO and President. Founder and former CEO, David DeCurtis, ... “DeCurtis Corporation has been on an incredible journey for the last twenty years, ...
(Date:6/11/2020)... ... June 08, 2020 , ... Greffex, a leading ... use of proprietary clean viral vectors, recently announced a key manufacturing agreement with ... platform is the world’s most successful gene therapy delivery vehicle (vector) with broad ...
Breaking Biology Technology:
Cached News: